RADIFY®

We’ve developed RADIFY® to enable radiologists to diagnose more images, more consistently and in less time – whilst prioritising care for people who need it most.

Trained and validated by radiologists for medical practitioners, our products detect and highlight abnormalities across Xrays, Mammograms and Ultrasounds.

RADIFY® for Chest

Chest radiography is the most readily available, cost effective and appropriate imaging modality for the assessment and initial diagnosis of common respiratory diseases.

The RADIFY® Platform for COVID and Tuberculosis detects, labels and triages the most urgent cases providing a summarised report to the doctors within seconds.

Additional Tele-radiology support is provided by our team of radiologists.

RADIFY® for Breast Imaging
RADIFY® for mammography assists radiologists in the diagnosis and screening of breast lesions.

Mammography has been the frontline screening tool for breast cancer for decades. The early detection of breast cancer is life-saving especially in under resourced countries.

We’ve developed RADIFY® for mammograms as a clinical decision support tool for radiologists when screening for breast cancer.
RADIFY® for Ultrasound
RADIFY® AI solution integrated with the mobile ultrasound tool will achieve radiology-level performance for point-of-care diagnosis on ultrasound images.

Ultrasound is a relatively inexpensive and portable modality of diagnosis for life-threatening diseases and for use as point-of-care.

The procedure is a non-invasive tool and it quickly gives doctors information necessary to make a diagnosis.

Head Office: United Kingdom – Coveham House, Downside Bridge Road, Cobham, KT11 3 EP

South African Office: One-on Jameson Building, 1 Jameson Ave, Melrose Estate, Jhb, 2196

© 2023, Envisionit Deep AI (Pty) Ltd. 2019/038117/07. All Rights Reserved. Terms & Conditions apply.